Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Venous Thrombosis 5 Venous Thromboembolism 3 Pulmonary Embolism 2 Thrombosis 1 Thromboembolism 1 Myeloproliferative Disorders 1 Hemostatic Disorders 1 Embolism 1

Interventions

Cyclophosphamide 87 fludarabine phosphate 86 Peripheral Blood Stem Cell Transplantation 71 Mycophenolic Acid 58 Tacrolimus 57 Busulfan 57 Whole-Body Irradiation 55 Antilymphocyte Serum 47 Cyclosporine 46 fludarabine 39 Methotrexate 38 Filgrastim 38 Melphalan 32 ruxolitinib 30 Cytarabine 30 Radiotherapy 27 Azacitidine 23 Etoposide 21 Methylprednisolone 20 Cord Blood Stem Cell Transplantation 18 Specimen Handling 15 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Decitabine 15 Biopsy 15 Flow Cytometry 14 Cyclosporins 14 Alemtuzumab 14 thymoglobulin 13 venetoclax 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myeloproliferative Disorders × edoxaban × Clear all

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡